This method uses immunohistochemistry (IHC) to assess antibody binding patterns across a diverse panel of human and animal frozen tissue sections. It is considered the gold standard for predicting a therapeutic antibody's safety profile prior to Phase I human studies.
Antibody Cross-Reactivity Evaluation Services
Introduction of Antibody Cross-Reactivity
In biological research, antibodies are indispensable tools, but their effectiveness is wholly dependent on their specificity. The phenomenon of cross-reactivity, where an antibody binds to unintended targets, is a significant threat to data integrity, regulatory compliance, and research timelines. This issue, often contributing to a "reproducibility crisis," has led to a growing demand for rigorous antibody validation standards from both the scientific community and regulatory bodies. Our services are designed to provide a definitive solution to this problem.
Methods of Antibody Cross-Reactivity Evaluation
Creative Biolabs employs a multi-faceted approach to antibody cross-reactivity evaluation. Our methods are designed to provide a comprehensive and nuanced understanding of an antibody's binding profile.
Tissue Cross-Reactivity (TCR) Studies
Protein and Epitope Microarrays
This cutting-edge method uses high-density arrays containing thousands of proteins or specific epitopes to screen for binding. It can test antibodies against proteins in their native or denatured conformations.
Immunoblotting (Western Blot)
This classic technique is used to assess an antibody's ability to bind its target within a complex mixture of proteins from different species or cell lines. It helps visualize any unintended bands that may indicate cross-reactivity.
In Silico Analysis
We use bioinformatic tools to perform homology searches of an antibody's immunogen sequence against known protein databases. This helps predict potential cross-reactive targets based on sequence similarity.
Microbead-Based Screening
This innovative method expresses a target protein's extracellular domain and links it to fluorescent microbeads, which then serve as a positive control for flow cytometry. It is a powerful way to quickly screen a large number of antibodies.
Our Antibody Cross-Reactivity Evaluation Services
Creative Biolabs provides Antibody Cross-Reactivity Evaluation Services designed to eliminate uncertainty and build confidence in your research. We offer a comprehensive suite of advanced technologies, from gold-standard TCR studies to cutting-edge protein microarrays and molecular modeling. Our expert team provides detailed analysis and strategic guidance, ensuring your projects are supported by unassailable data. Our workflow is designed to be a transparent and collaborative process, ensuring you receive the highest quality data and analysis tailored to your specific project needs. We work closely with you from initial consultation to final delivery.
Contact Our Team for More Information and to Discuss Your Project
Why Choose Us
Our Antibody Cross-Reactivity Evaluation Services provide more than just a data point; they offer a complete solution to a critical problem in modern biology. We provide tools to build your research on a foundation of confidence, enabling you to accelerate your progress and avoid costly setbacks. Our cross-reactivity evaluation services are applicable across a wide range of fields and applications.
Contact Us
In addition to Antibody Cross-Reactivity Evaluation Services, Creative Biolabs offers a suite of complementary services designed to provide a more comprehensive understanding of antibody behavior and specificity, including Antibody Off-Target Binding Evaluation Service and Molecular Docking based Antibody Cross-Reactivity Prediction Service. These services help clients address off-target binding issues and predict potential cross-reactivity at the molecular level, ensuring a thorough analysis from all angles. Ready to ensure your antibodies are the reliable tools you need them to be? Contact us to discuss your project.
FAQs
How do you determine if my antibody recognizes a conserved epitope for vaccine development?
The specialized multiplexed assay was designed to analyze antibody binding to multiple allelic variants at a single B-cell level, definitively distinguishing between the two and identifying antibodies that target truly conserved epitopes.
What if my antibody is for a non-model organism where reagents are scarce?
This is a core area of our expertise. We can use our microbead-based screening method to express your target antigen and validate antibodies against it without the need for biological samples from the organism itself. This approach saves significant time and resources and is particularly valuable for species where obtaining cell lines or tissues is difficult.
Are your services suitable for therapeutic antibody validation for regulatory submissions?
Our services are designed to meet and exceed regulatory standards. We offer a gold-standard Tissue Cross-Reactivity (TCR) analysis that is mandated by regulatory bodies for therapeutic antibody safety assessment before Phase I clinical trials. Our comprehensive reports provide detailed data and expert analysis required for your submissions.
How do your services compare to simple sequence homology analysis?
Sequence homology is an important first step, and we include it in our initial analysis. However, it's not enough on its own because cross-reactivity is highly epitope-dependent and can occur even without sequence similarity. Our services provide a deeper, functional analysis by characterizing binding to proteins in their native conformation, mapping specific epitope contributions, and using advanced molecular modeling to understand the binding mechanism.
For research use only. Not intended for any clinical use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
